IL17F and B-cell chronic lymphocytic leukemia: The percentage of IL-17F-expressing CD4+ T cells trended higher in CLL patients as compared to healthy age-matched individuals, but the difference did not reach statistical significance (p = 0.099) (Fig. 1b).